We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Par Calls Novartis' Lotrel Patent Unenforceable

Law360 (September 6, 2007, 12:00 AM EDT) -- Par Pharmaceutical Companies Inc. has fired off the latest salvo in its battle with Swiss pharmaceutical giant Novartis International AG over the billion-dollar hypertension drug Lotrel, asking a New Jersey court...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.